Cleared Special

K160887 - Cook Intraosseous Infusion Needles

K160887 is an FDA 510(k) clearance for Cook Intraosseous Infusion Needles, manufactured by Cook Incorporated. The device is a Class 2 General Hospital device with product code FMI cleared through the Special 510(k) pathway after a 117-day FDA review.

K160887 · Cook Incorporated · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
117d
Days
Class 2
Risk

K160887 is an FDA 510(k) clearance for the Cook Intraosseous Infusion Needles. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Cook Incorporated (Bloomington, US). The FDA issued a Cleared decision on July 26, 2016 after a review of 117 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K160887

510(k) Number K160887 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2016
Decision Date July 26, 2016
Days to Decision 117 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 129d · This submission: 117d
Pathway characteristics
Modification to existing cleared device.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 581
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K160887.
CPL Insulin Pen Needle
K151090 · Cpl Co., Ltd. · Sep 2016
CareSens Pen Needle, Softip Pen Needle
K160575 · Yidobio, Inc. · Sep 2016
Insulin Pen Needle
K153706 · SteriLance Medical (Suzhou), Inc. · Aug 2016
JSM Insulin Pen Needle
K152166 · Jeesung Medical Co., Ltd. · Jul 2016
BD SafeAssist
K161553 · Becton, Dickinson and Company · Jul 2016
Unifine Pentips/ Unifine Pentips Plus
K152339 · Owen Mumford, Ltd. · Jun 2016